Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy

被引:4
|
作者
Zhang, Hao [1 ]
Huo, Junyu [1 ]
Jiang, Wanying [1 ]
Shan, Qijun [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China
关键词
dilated cardiomyopathy; hub gene; gene expression omnibus; bioinformatics; ACUTE KIDNEY INJURY; HEART-FAILURE; INTERNATIONAL-SOCIETY; TASK-FORCE; PROENKEPHALIN; DYSFUNCTION; DOXORUBICIN; EXPRESSION; IDENTIFICATION; MANAGEMENT;
D O I
10.3892/mmr.2020.11145
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dilated cardiomyopathy (DCM) is a primary cardiomyopathy with high mortality. The aim of the present study was to identify the related genes in DCM. The four expression profiles (GSE17800, GSE21610, GSE42955 and GSE79962) downloaded from the Gene Expression Omnibus (GEO) database were analyzed using RankProd and metaMA R packages to identify differentially expressed genes (DEGs). DEGs were uploaded to the Database for Annotation, Visualization and Integrated Discovery (DAVID), for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. A protein-protein interaction (PPI) network of the DEGs was constructed using the STRING database. In addition, hub genes were identified using the Cytoscape plugin cytoHubba. A mouse DCM model, which established via intraperitoneal injection with doxorubicin (DOX), was used to validate the hub genes. A total of 898 DEGs were identified across the four microarrays. Furthermore, GO analysis demonstrated that these DEGs were mainly enriched in cell adhesion, negative regulation of cell proliferation, negative regulation of apoptotic process and potassium ion transport. In addition, KEGG analysis revealed that DEGs were mainly enriched in the ECM-receptor interaction, the p53 signaling pathway, cardiac muscle contraction and the hypoxia-inducible factor signaling pathway. Proenkephalin (PENK), chordin like 1 (CHRDL1), calumenin (CALU), apolipoprotein L1, insulin-like growth factor binding protein 3 (IGFBP3) and ceruloplasmin (CP) were identified as hub genes in the PPI network. Furthermore, the expression levels of PENK, CHRDL1, IGFBP3, CP and CALU in hearts with DCM were validated using a mouse model. In conclusion, the present study identified six hub genes related to DCM. Therefore, the present results may provide a potential mechanism for DCM involving these hub genes, which may serve as biomarkers for screening and diagnosis in the clinic.
引用
收藏
页码:915 / 925
页数:11
相关论文
共 50 条
  • [21] Proteomic analysis of potential biomarkers of recent onset dilated cardiomyopathy for prediction of the therapy outcome
    Pudil, R. Radek
    Klimentova, J.
    Rehulka, P.
    Vozandychova, V.
    Jurcova, I.
    Lazarova, M.
    Hrecko, J.
    Stulik, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 151 - 151
  • [22] Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis
    Guo, Qixin
    Qu, Qiang
    Wang, Luyang
    Liao, Shengen
    Zhu, Xu
    Du, Anning
    Zhu, Qingqing
    Cheang, Iokfai
    Gao, Rongrong
    Li, Xinli
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2022, 27 (08):
  • [23] Bioinformatics prediction of potential mechanisms and biomarkers underlying dilated cardiomyopathy
    Liu, Zhou
    Song, Ying-Nan
    Chen, Kai-Yuan
    Gao, Wei-Long
    Chen, Hong-Jin
    Liang, Gui-You
    WORLD JOURNAL OF CARDIOLOGY, 2022, 14 (05): : 282 - 296
  • [24] MICROARRAY ANALYSIS REVEALS NOVEL TARGET AUTOANTIGENS IN DILATED CARDIOMYOPATHY
    Mueller, Anna-Maria
    Bangert, Anna
    Oettl, Renate
    Vukovic, Vesna
    Doesch, Andreas
    Katus, Hugo
    Kaya, Ziya
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E742 - E742
  • [25] Integrated analysis of WGCNA and machine learning identified diagnostic biomarkers in dilated cardiomyopathy with heart failure
    Zhu, Yihao
    Yang, Xiaojing
    Zu, Yao
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [26] INTEGRATED GENOME ANALYSIS OF UTERINE LEIOMYOSARCOMAS TO IDENTIFY DRIVER MECHANISMS AND THERAPEUTIC TARGETS
    Moisse, M.
    Cuppens, T.
    Colas, E.
    Reventos, J.
    Garcia, A.
    Huvila, J.
    Zikan, M.
    Matias-Guiu, X.
    Lambrechts, D.
    Amant, F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 633 - 633
  • [27] Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis
    Wu, Man-Ning
    Zhou, Dong-Mei
    Jiang, Chun-Yan
    Chen, Wei-Wen
    Chen, Jia-Chi
    Zou, Yue-Min
    Han, Tao
    Zhou, Li-Jia-Ming
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [28] Bioinformatic analysis of ferroptosis related biomarkers and potential therapeutic targets in vitiligo
    Liu, Linli
    Deng, Lingli
    Guan, Li
    Hu, Yuan
    Li, Qianying
    Yu, Chunshui
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [29] An Integrated Framework to Identify Prognostic Biomarkers and Novel Therapeutic Targets in Hepatocellular Carcinoma-Based Disabilities
    Rahman, Md. Okibur
    Das, Asim
    Naeem, Nazratun
    Hossain, Md. Ali
    Alam, Md. Nur
    Azad, Akm
    Alyami, Salem A.
    Alotaibi, Naif
    Al-Moisheer, A. S.
    Moni, Mohammod Ali
    BIOLOGY-BASEL, 2024, 13 (12):
  • [30] Integrated Network and Microarray Analysis to Identify New Biomarkers of Heart Failure after Myocardial Infarction
    Devaux, Yvan
    Yvorra, Celine
    Vausort, Melanie
    Jeanty, Celine
    Azuaje, Francisco
    Wagner, Daniel
    CIRCULATION, 2008, 118 (18) : S865 - S865